Ranbaxy Laboratories soars as Supreme Court dismisses PIL against company

25 Jun 2013 Evaluate

Ranbaxy Laboratories is currently trading at Rs. 331.70, up by 6.20 points or 1.90% from its previous closing of Rs. 325.50 on the BSE.

The scrip opened at Rs. 325.75 and has touched a high and low of Rs. 337.90 and Rs. 301.75 respectively. So far 544363 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 578.30 on 04-Sep-2012 and a 52 week low of Rs. 323.00 on 24-Jun-2013.

Last one week high and low of the scrip stood at Rs. 366.00 and Rs. 323.00 respectively. The current market cap of the company is Rs. 13171.13 crore.

The promoters holding in the company stood at 63.52% while Institutions and Non-Institutions held 20.58% and 13.80% respectively.

The Supreme Court has dismissed a public-interest litigation (PIL) filed against Ranbaxy Laboratories for allegedly manufacturing and selling substandard drugs in India. The petitioner failed to bring in evidence against Ranbaxy.

Earlier in June, PIL appeal was filed in the Supreme Court against the company’s directors for allegedly manufacturing and selling adulterated drugs. Manohar Lal Sharma, the petitioner, also sought sealing of the company’s manufacturing facilities at Paonta Sahib and Devas in Madhya Pradesh, besides mentioning the Central Bureau of Investigation (CBI) as one of the respondents in the case. The PIL came in the wake of the Indian pharma major being fined $500 million by the U.S. Food and Drug Administration (USFDA) for making and selling 'adulterated' drugs.

Ranbaxy Laboratories, India’s largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.

 

Peers
Company Name CMP
Sun Pharma Inds. 1787.90
Dr. Reddys Lab 1280.65
Cipla 1500.85
Zydus Lifesciences 918.75
Lupin 2091.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×